🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to assess the efficacy, safety of MRG003 as ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-09-04
Trial ID
NCT04838548
Treatments Being Tested
This first-in-human study will evaluate the recommended dose for further cl...
Status
Terminated
Location
Sarah Cannon Research Institute - TN Oncology
Start Date
2020-06-19
Trial ID
NCT04441099
Treatments Being Tested
In Phase I, This study will explore the tolerability and safety of RC118 in...
Status
Recruiting
Location
Zhongshan Hospital Affiliated to Fudan University
Start Date
2022-03-03
Trial ID
NCT05205850
Treatments Being Tested
This is a single-arm, multicenter, phase II study designed to evaluate the ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-10
Trial ID
NCT07542717
Treatments Being Tested
The objective of this study is to assess the safety, efficacy, pharmacokine...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2022-01-19
Trial ID
NCT05141747
Treatments Being Tested
This is a multicenter, two-arm, exploratory clinical study designed to eval...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2026-05
Trial ID
NCT07528898
Treatments Being Tested
This is a Phase 1, first in human (FIH), Open-Label, Dose Escalation, Dose ...
Status
Recruiting
Location
Site-111
Start Date
2025-03-20
Trial ID
NCT06874335
Treatments Being Tested
In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Start Date
2023-03-20
Trial ID
NCT05798156
Treatments Being Tested
Phase 1/2 trial to study the safety, pharmacokinetics and preliminary effic...
Status
Terminated
Location
The first affiliated hospital, Zhejiang Unviersity school of medicine
Start Date
2022-11-25
Trial ID
NCT05611853
Treatments Being Tested
HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which spec...
Status
Recruiting
Location
The Second Affiliated Hospital Zhejiang University
Start Date
2024-10-03
Trial ID
NCT06825624
Treatments Being Tested